Breaking News
Sort by:
Top Post
Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and […]
Kuria Therapeutics Completes FDA Pre-IND Consultation for Topical Nrf2 Activator for Corneal Endothelial Disease
Kuria Therapeutics, a pharmaceutical company developing novel ophthalmic and dermal therapeutics, is pleased to announce […]
Mitsubishi Tanabe Pharma America Announces More Than 10,000 People with ALS Treated with RADICAVA ORS® and/or RADICAVA®
Mitsubishi Tanabe Pharma America today announced that more than 10,000 people with amyotrophic lateral sclerosis […]
Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease
UCB, a global biopharmaceutical company, and Aitia, the leader in the application of Causal AI […]
Kurve Therapeutics Announces Development of New Intellectual Property to Target Drug Delivery in the Brain
Today, Kurve Therapeutics announced it has filed for new intellectual property on its nose to […]
Mirum Announces Label Expansion for LIVMARLI in the United States to Include Infants Three Months of Age and Older
Mirum Pharmaceuticals today announced that the United States Food and Drug Administration (FDA) has approved […]
InDex Pharmaceuticals Announces Positive Results from a Pharmacokinetic (PK) Study with Cobitolimod
InDex Pharmaceuticals has announced positive results from a pharmacokinetic (PK) study with cobitolimod in patients […]
China National Medical Products Administration Accepts Regulatory Submission for Nucala (mepolizumab) in Severe Eosinophilic Asthma
GSK today announced that the China National Medical Products Administration has accepted for review a […]
Accord Healthcare Adds Generic Drug Approved for the Treatment of Relapsing MS
Accord Healthcare, a leading generic pharmaceutical company, has added Teriflunomide to its portfolio of oral […]
Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval
Pfizer has announced the US Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the […]
AnnJi Pharmaceutical Announced a Licensing Agreement With Avenue Therapeutics For The Treatment Of Kennedy's Disease
AnnJi Pharmaceutical has entered into an exclusive license agreement with Avenue Therapeutics for the development and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more